Aurobindo Pharma receives USFDA approval for hypertension drug

Aurobindo Pharma now has a total of 138 abbreviated new drug application (ANDA) approvals from the USFDA

Aurobindo Pharma said it has received final approval from the US health regulator to market and manufacture Ramipril Capsules, used for treating hypertension, in the American market.

The company has received approval from the US Food and Drug Administration (USFDA) for Ramipril Capsules in strengths of 1.25mg, 2.5mg, 5mg and 10mg, Aurobindo Pharma said in a statement.

Ramipril Capsules, which are the generic equivalent of King Pharmaceuticals Altace, are indicated for the treatment of hypertension and falls under the cardiovascular therapeutic segment, it said.

"The product has a market size of approximately $95 million for the twelve months ending September 2010, according to IMS and will be launched soon," the company said.

The Hyderabad-based firm now has a total of 138 abbreviated new drug application (ANDA) approvals from the USFDA, it said.

On Friday, Aurobindo Pharma ended 2.77% down at Rs175 on the Bombay Stock Exchange, while the benchmark Sensex declined 0.63% to 18,268.54.

User

Glenmark gets final USFDA nod for skin ointment‎

Based on IMS health data for the 12-month period ending March 2011, Mupirocin ointment garnered annual sales of $55 million and achieved a 9% increase in growth compared to the same period last year

Drug firm Glenmark said it has received final approval from the US health regulator for its generic Mupirocin ointment, used for the treatment of bacterial skin infections.

Glenmark Generics, the US subsidiary of Glenmark Generics, has been granted a final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (USFDA) for Mupirocin Ointment USP 2%, the company said in a statement.

"Based on IMS health data for the 12-month period ending March 2011, Mupirocin ointment garnered annual sales of $55 million and achieved a 9% increase in growth compared to the same period last year," Glenmark said.

The ointment is used for treatment of impetigo, a bacterial skin infection, and is available in a 22-gram tube.

The company's current portfolio consists of 68 products authorised for distribution in the American market. It has 39 ANDAs pending approval, Glenmark said.

On Friday, Glenmark ended 1.33% up at Rs312.70 on the Bombay Stock Exchange, while the benchmark Sensex declined 0.63% to 18,268.54.

User

Tata Motors wins order from Siddhivinayak Logistics

Tata Motors will supply 1,111 trucks to Siddhivinayak Logistics during the year

Tata Motors said that it has received its largest order ever of Medium & Heavy Commercial Vehicles from a single fleet owner. The order is from Siddhivinayak Logistics Ltd (SVLL) to supply 1,111 M&HCV trucks, to be delivered during the year.

Based in Surat, SVLL is one of the largest fleet owners in the country, owning a fleet of over 2000 commercial vehicles. The company operates across diverse segments like steel, cement, tractors, chemicals, machinery and is a pioneer in new segments like commercial vehicle chassis carriers. SVLL plans to start transporting farm fresh fruits and vegetables through refrigerated containers on the Tata Prima.

Vinod Sahay, head-sales & marketing (M&HCV Trucks), Tata Motors said, "We will be commencing deliveries in this month and plan to complete the order by end of this financial year."  

Tata Motors M&HCV sales in May 2011 saw a growth of 12% over May 2010. The company currently has 70% market share in M&HCV trucks.  
 
On Friday, Tata Motors ended 0.09% down at Rs1,019.75 on the Bombay Stock Exchange, while the benchmark Sensex declined 0.63% to 18,268.54.

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)